A Prospective, Registry-based, Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant: The Migraine Observational Nurtec Pregnancy Registry (MONITOR)

First published 26/01/2022

Last updated 09/07/2025

EU PAS number:

EUPAS45356

Study

Ongoing

Documents

Study protocol

Initial protocol

C4951005_BHV3000-402_BC102842-01_Protocol_25Apr2023_clean_signed

English (1.27 MB - PDF)View document

Updated protocol

C4951005_MONITOR PROTOCOL CLEAN_V2.0_08NOV2022.pdf

First published: 08/07/2025

English (745.02 KB - PDF)View document

C4951005_MONITOR PROTOCOL CLEAN_V3.0_25APR2023.pdf

First published: 30/06/2025

English (1.3 MB - PDF)View document

C4951005_MONITOR PROTOCOL CLEAN_V4.0_27FEB2024.pdf

First published: 25/06/2025

English (716.9 KB - PDF)View document

C4951005_MONITOR PROTOCOL CLEAN_V5.0_18OCT2024.pdf

First published: 13/06/2025

English (688.86 KB - PDF)View document

Study results

Study report

Other information

Secondary tabs